Athenex - M&A Summary and Business Overview

Life ScienceCompany

Athenex M&A Summary

Athenex has acquired 2 companies, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms.

Athenex’s largest acquisition to date was in 2021, when it acquired Kuur Therapeutics for $185M. Athenex has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Athenex Business Overview

Where is Athenex headquartered?

Athenex is headquartered in Buffalo, New York.

What is Athenex’s revenue?

Athenex disclosed revenue of 120M USD for 2021 and 144M USD for 2020.

How many employees does Athenex have?

Athenex has 652 employees.

What sector is Athenex in?

Athenex is a life science company.

When was Athenex founded?

Athenex was founded in 2003.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1
  • M&A Advisors 2

Athenex

Athenex, Inc.

Conventus Building Suite 600 1001 Main Street,
Buffalo, New York 14203
United States,
(716) 427-2950
www.athenex.com

Athenex is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. Athenex has organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform, and a Global Supply Chain Platform. The Company’s current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) Cell therapy, and (4) Arginine deprivation therapy. Athenex was founded in 2003 and is based in Buffalo, New york.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 1 - 1 - - - 2
vol $185M $185M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Kuur Therapeutics 2021-05-04 185M USD Add-on Acquisition
London, United Kingdom · www.kuurtx.com
QuaDPharma LLC 2014-09-09 - Add-on Acquisition
New York, New York · www.qdpharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 185M (100%) - -
Total 2 $185M - -

By Geo

State/Country Buy Value Sell Value
United Kingdom 1 185M - -
United States 1 - - -
  New York 1 - - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) 185M (100%) - -
Total 2 $185M - -

Top M&A Advisors

Financial Deals
Leerink Partners
1
Legal Deals
Cooley
1

Deal Values

buy # Total
$100M to $1B 1 $185M
TOTAL $185M
Largest Kuur Therapeutics
$185M (2021-05-04)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.